ADVERTISEMENT

Jyothy Labs Q2 Review — Weak Quarter Despite Volume Growth, Says Motilal Oswal Maintaining 'Neutral' Stance

Market share gains, the success of new launches, a recovery in personal care, and the turnaround of HI portfolio will be crucial for Jyothy Labs’ earnings growth.

<div class="paragraphs"><p>Jyothy Laboratories expects Ebitda margin to be in the range of 16%- 17% in H2 FY26. (Source: Company website)</p></div>
Jyothy Laboratories expects Ebitda margin to be in the range of 16%- 17% in H2 FY26. (Source: Company website)
Jyothy Laboratories posted flat YoY sales growth in Q2 FY26, with volumes rising 3% (estimate: 4%; 1QFY26 4%). The difference between value and volume growth was primarily due to MRP reductions, higher grammage, and promotional price-offs in select categories. Jyothy Labs expects a 2%-2.5% value volume gap at the overall level going forward.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit